Skip to main content

Table 6 Univariate and multivariate survival analysis of MetS for progression-free and overall survival in 573 EOC patients

From: Case-control study of metabolic syndrome and ovarian cancer in Chinese population

Variable

Cases (N)

Progression-free survival (PFS)

Overall survival (OS)

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Media of PFS

P a

OR

95% CI For HR

P b

Media of OS

P a

OR

95% CI For HR

P b

MetS

  

<0.001

1.482

1.087–2.022

0.013

 

<0.001

1.702

1.195–2.424

0.003

Yes

144

39

    

67

    

No

429

42

    

71

    

BMI(kg/m2)

  

0.006

0.926

0.746–1.150

0.486

 

0.002

0.873

0.678–1.123

0.290

≥25

209

40

    

67

    

<25

364

44

    

70

    

DM

  

0.071

1.087

0.883–1.338

0.430

 

0.077

1.096

0.850–1.413

0.480

Yes

161

40

    

69

    

No

412

41

    

70

    

HBP

  

0.074

0.992

0.789–1.247

0.942

 

0.753

0.778

0.594–1.019

0.068

Yes

176

39

    

69

    

No

397

42

    

72

    

TG (mmol/L)

  

0.556

0.954

0.773–1.178

0.661

 

0.451

0.949

0.737–1.221

0.682

TG<1.70

170

41

    

70

    

TG ≥ 1.70

403

41

    

69

    

HDL-C(mmol/L)

  

0.286

1.024

0.796–1.319

0.852

 

0.097

1.115

0.839–1.481

0.454

HDL-C ≥ 1.0

481

41

    

70

    

HDL-C<1.0

92

40

    

67

    
  1. MetS metabolic syndrome, P a P value, log rank test, OR odds ratio, CI confidence interval, P b P value, Cox regression